Haleon Pakistan Limited (PSX:HALEON)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
732.07
+1.94 (0.27%)
At close: May 27, 2025
181.15%
Market Cap 85.69B
Revenue (ttm) 39.28B
Net Income (ttm) 5.28B
Shares Out 117.05M
EPS (ttm) 45.08
PE Ratio 16.24
Forward PE n/a
Dividend 20.00 (2.73%)
Ex-Dividend Date Mar 11, 2025
Volume 85,788
Average Volume 66,517
Open 727.00
Previous Close 730.13
Day's Range 727.00 - 739.44
52-Week Range 242.00 - 975.00
Beta 0.44
RSI 44.94
Earnings Date Aug 28, 2025

About Haleon Pakistan

Haleon Pakistan Limited engages in the manufacture, marketing, and sale of consumer healthcare products in Pakistan, rest of Asia, Africa, Australia, North America, the Middle East, and Europe. The company offers oral health, pain relief, wellness and nutrition, and respiratory health products, as well as over-the-counter pharmaceutical products. It sells its products primarily under the Panadol, CaC-1000 Plus, Sensodyne, paradontax, T-Day, ENO, Hydrozole, Qalsium-D, and Voltral Emulgel brands. The company also exports its products to Vietnam, ... [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 450
Stock Exchange Pakistan Stock Exchange
Ticker Symbol HALEON
Full Company Profile

Financial Performance

In 2024, Haleon Pakistan's revenue was 37.21 billion, an increase of 17.70% compared to the previous year's 31.61 billion. Earnings were 4.58 billion, an increase of 359.85%.

Financial Statements

News

There is no news available yet.